HSIC · Henry Schein Inc
Price
Snapshot
50 fields · last close| Market Cap | $9.63B |
| P/E | 23.89 |
| Float | 97.22M |
| Beta | 0.86 |
| Volatility | 21.6% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | Moderate |
| Clavix score | 85.4 |
| Price | 84.61 |
| Change | −2.05% |
| Prev Close | 86.38 |
| Open | 87.38 |
| Day Low | 85.84 |
| Day High | 88.13 |
| Avg Vol | 1 |
| Avg $ Vol | $115.2M |
| 52W High | 92.18 |
| 52W Low | 61.95 |
| 52W Pos | 75.0% |
| From High | −8.21% |
| From Low | +36.58% |
| Max DD 1Y | −17.23% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −0.69% |
| SMA 50 | −3.17% |
| SMA 200 | +4.88% |
| RSI (14) | 52.6 |
| Vol 30D | 19.1% |
| Vol 90D | 20.1% |
| 1Y Range | 62–92 |
| Daily bars | 536 |
| Perf Week | +2.82% |
| Perf Month | +1.58% |
| Perf Quarter | +0.21% |
| Perf Half Y | +9.58% |
| Perf Year | +36.57% |
| Perf YTD | +10.14% |
| Prev Day | −2.05% |
| Clavix | A- |
| Debt / Eq | 0.32 |
| Curr Ratio | 1.38 |
| Int Cover | 5.4× |
| FCF Margin | 5.4% |
| Rev Growth | +4.0% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 2 / 49 |
What HSIC does
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services.
It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services.
The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers.
The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics.
Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Clavix risk grade
regraded every trading dayHSIC grades A-, 85.4 of 100. Steadiest on Price Stability (70), most exposed on Sector Resilience (67, steady). 4 of the 4 weighted dimensions sit above the Health Care median. Ranks 2 of 49 in Health Care by Clavix score.
How rough the ride is
| HSIC | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.86 | 0.84 |
| Volatilityannualized | 21.6% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −17.2% | — |
| Typical daily movemedian absolute daily change | 0.92% | — |
| Days beyond ±3%of the last 252 sessions | 14 (6%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| HSIC | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.86 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| HSIC | |
|---|---|
| 1 week | +2.8% |
| 1 month | +1.6% |
| Year to date | +10.1% |
| 1 year | +36.6% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| HSIC | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 4 Aug |
| Average score0 most bearish, 100 most bullish | 65 |
| Bullish · bearisharticles above 60 · below 40 | 21 · 3 |
| Directionarticles whose tone is improving vs worsening | 21 ↑ 3 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| HSIC | |
|---|---|
| Revenue growthyear over year | +4.0% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openHenry Schein has appointed Emmanuel Caprais as its new CFO. The change is part of a broader wave of leadership transitions at the company that has also included the appointment of a new CEO.
Henry Schein has appointed Emmanuel Caprais as its new Chief Financial Officer. The change is part of a recent wave of leadership changes at the company, which also includes a new CEO.
Henry Schein announced that Emmanuel Caprais will become its next Chief Financial Officer in November 2026, replacing the current CFO Ronald N. South.
Henry Schein announced that Emmanuel Caprais, formerly CFO of ITT, will become Henry Schein's CFO effective November 4, 2026, after joining as an advisor on October 12, 2026. Current CFO Ronald South will move into a Senior Advisor role, and the company plans to add new leadership positions focused on strategy, transformation, and AI-enabled technology.
Henry Schein announced Emmanuel Caprais, formerly CFO of ITT, Inc., as its new Chief Financial Officer effective November 4, 2026. He will join the company as Senior Financial Advisor on October 12 to support the transition, while current CFO Ronald N. South moves into a senior advisory role after 18 years with the company.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| GKOS | Glaukos Corp | B | $9.72B | — | 0.73 | Compare |
| PODD | Insulet Corp | B- | $9.79B | 26.07 | 1.08 | Compare |
| GMED | Globus Medical Inc | B | $10.30B | 19.24 | 0.97 | Compare |
| ALGN | Align Technology Inc | B | $10.46B | 25.30 | 1.74 | Compare |
| MOH | Molina Healthcare Inc | B | $10.82B | 22.93 | 0.73 | Compare |
| UHS | Universal Health Services Inc | A- | $10.91B | 7.15 | 1.11 | Compare |
| COO | Cooper Companies Inc | B- | $11.02B | 19.32 | 0.82 | Compare |
| HNGE | Hinge Health Inc | C+ | $8.00B | 73.36 | 1.53 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.